Mechanisms of augmented tumor immunogenicity via ATR inhibition in Merkel cell carcinoma
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接:
https://www.ncbi.nlm.nih.gov/sra/SRP667869
下载链接
链接失效反馈官方服务:
资源简介:
There is an urgent unmet need to develop novel therapeutic strategies for tumors that do not respond to immune checkpoint inhibition (ICI) via PD-1 pathway blockade. The ATR-mediated DNA replication checkpoint has been reported to have immune-augmenting properties; however, the mechanisms underlying these properties are not well characterized. Here we explore the potential immunogenic effects of ATR inhibition in Merkel cell carcinoma (MCC), a cancer that is particularly relevant due to its high proliferative index and frequent response to anti-PD-(L)1 therapy. ATR inhibition induced tumor cell cytotoxicity in both Merkel cell polyomavirus-positive and UV-induced MCC cell lines in the absence of exogenous DNA damage. ATR inhibition alone or in combination with low-dose radiation induced numerous proinflammatory TNF-NF-?B signals as assessed via bulk transcriptomic profiling. These included increased expression of MHC class-I alleles, antigen processing machinery, interleukins, chemokines and interferon genes associated with anti-tumor immune responses in diverse tumor types. In parallel, we observed enhanced surface exposure of the âeat-meâ signal calreticulin on MCC cells and subsequent phagocytosis by human monocyte-derived macrophages. Given that MCC tumors are often cGAS-STING-deficient (including two cell lines examined here), these ATRi-induced mechanisms are significant as they were activated regardless of cGAS-STING functional status. These data provide a mechanistic basis for the clinical evaluation of ATRi in advanced ICI-refractory MCC (NCT05947500), and suggest biomarkers that may be associated with response in human MCC tumors treated with ATRi. Overall design: Early passaged WaGa, MKL2, MCC26 and MCC13-HL cell lines were used (sub-cultured less than 25 times). 72 hours of ATRN-119 (100 nM for MCPyV-positive and 250 nM for MCPyV-negative) ± 4 Gy radiation treatment was initiated in triplicate for cells seeded in 10 cm tissue-culture dishes. Untreated cells were used as negative control. Harvested cells were submitted for RNA extraction, library preparation and sequencing (DNBseq platform, BGI Genomics, Cambridge, MA, USA). Raw paired-end reads (~ 30 million per sample; 100 base pair read length) were quality-checked, adapter-trimmed, and aligned to GRCh38 with Bowtie236. Genes with counts less than 10 across all samples were filtered out. The subsequent raw RNA-Seq count data were normalized using FPKM (fragments per exonic kilobase per million) with effective library sizes estimated using TPM (transcripts per million), followed by log2 transformation with a pseudocount of 2, as implemented in the edgeR R/Bioconductor package37 and used for further analyses. Differential analysis at the gene level was performed using the Limma package38, with false discovery rate method used to adjust the p-values for multiple testing. Genes with an absolute log2 fold change of at least 0.5, normalized against mock-treated cells, were considered either up or downregulated and used for relative quantification across different treatment groups. Statistical significance was defined by a Q value of = 0.05. Dot plots were generated using the R ggplot2 package39. Transformed expression data matrices were uploaded to an integrative cloud-based multi-omics RNA-seq data mining browser from BGI Genomics (âDr. Tomâ) and then used as input for computation of treatment-induced transcriptomic enrichment via the Molecular Signatures Database (MSigDB) hallmark gene set analysis. Hallmark interpretations were queried using a minimum of 15 and a maximum of 500 genes per set for statistically significant signatures. Distribution of normalized enrichment scores (NES) and gene set enrichment analysis (GSEA)-defined false discovery rate (FDR) significance threshold ? 0.05, along with leading edge (LE) gene set sizes for a characteristic biological phenotype, can be found in Supplemental Figure 3. Variable clustering of gene expression data across all samples was performed and visualized through principal component analysis.
创建时间:
2026-01-29



